Trial Profile
An Open-label, Randomized, Crossover Study to Evaluate the Safety and Pharmacokinetics After Multiple Administration of SLM0807 Alone and Multiple Co-administration of HKB0701/SLM0807 in Korean Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Metformin/voglibose (Primary) ; SLM 0807
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors CJ Corporation; HK inno.N
- 08 Jan 2010 New trial record